|
We are a specialty pharmaceutical company focused on identifying, acquiring,
and commercializing novel products that address significant patient needs. We
have multiple FDA-approved products on the market, and we seek to build a
portfolio of novel therapeutics that serve large medical needs, across a range
of conditions, through our in-house commercial team. Our commercial
infrastructure consists of a U.S.-based specialty sales force and an
international distribution network with presence in approximately fifty
countries.
We currently are focused on commercialization of four products, (i) Natesto®, a
testosterone replacement therapy, or TRT, (ii) Tuzistra®XR, a codeine based
antitussive, (iii) ZolpiMistTM, a short-term insomnia treatment and (iv),
MiOXSYS®, a novel in vitro diagnostic system for male infertility assessment.
|
|